Kamada LtdNASDAQ:KMDA
- LAST PRICE5.8000
- TODAY'S CHANGE (%)-0.0700 (-1.1925%)
- Bid / Lots5.8000/ 1
- Ask / Lots5.9200/ 1
- Open / Previous Close5.8300 / 5.8700
- Day Range
- 52 Week Range
- Volume33,052
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KMDA |
|---|---|---|
| 09:32 ET | 1497 | 5.81 |
| 09:33 ET | 800 | 5.8 |
| 09:37 ET | 300 | 5.804 |
| 09:39 ET | 1428 | 5.78 |
| 09:42 ET | 200 | 5.78 |
| 09:46 ET | 1080 | 5.78 |
| 09:51 ET | 2500 | 5.71 |
| 09:57 ET | 300 | 5.73 |
| 10:00 ET | 401 | 5.77 |
| 10:06 ET | 100 | 5.76 |
| 10:11 ET | 100 | 5.74 |
| 10:13 ET | 1000 | 5.7799 |
| 10:24 ET | 200 | 5.76 |
| 10:27 ET | 1856 | 5.78 |
| 10:38 ET | 1464 | 5.7801 |
| 10:47 ET | 450 | 5.81 |
| 11:00 ET | 200 | 5.805 |
| 11:38 ET | 555 | 5.74 |
| 12:01 ET | 400 | 5.775 |
| 12:10 ET | 728 | 5.785 |
| 12:37 ET | 600 | 5.78 |
| 12:42 ET | 100 | 5.79 |
| 12:50 ET | 500 | 5.815 |
| 12:51 ET | 200 | 5.82 |
| 12:55 ET | 400 | 5.81 |
| 01:06 ET | 100 | 5.805 |
| 01:18 ET | 100 | 5.8 |
| 01:29 ET | 337 | 5.8003 |
| 01:31 ET | 723 | 5.8 |
| 01:33 ET | 100 | 5.81 |
| 01:38 ET | 172 | 5.815 |
| 01:40 ET | 1000 | 5.8019 |
| 01:44 ET | 317 | 5.8 |
| 01:51 ET | 295 | 5.78 |
| 02:07 ET | 100 | 5.77 |
| 02:12 ET | 100 | 5.77 |
| 02:16 ET | 475 | 5.802 |
| 02:25 ET | 493 | 5.79 |
| 02:45 ET | 100 | 5.797 |
| 02:54 ET | 100 | 5.78 |
| 02:57 ET | 100 | 5.8 |
| 03:44 ET | 125 | 5.79 |
| 03:51 ET | 500 | 5.785 |
| 03:53 ET | 1668 | 5.77 |
| 03:55 ET | 100 | 5.795 |
| 03:57 ET | 100 | 5.79 |
| 04:00 ET | 634 | 5.8 |
Nov 14, 2024
DJ Kamada Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 1:56PM ET on Thursday Nov 14, 2024 by Dow Jones
1:56PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 6, 2024
Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 4, 2024
Kamada to Present at the Stifel 2024 Healthcare Conference, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kamada Ltd | 337.5M | 18.7x | -22.48% |
Sutro Biopharma Inc | 205.7M | -1.6x | --- |
Sangamo Therapeutics Inc | 391.5M | -2.7x | --- |
Karyopharm Therapeutics Inc | 105.9M | -1.1x | --- |
Arcturus Therapeutics Holdings Inc | 458.0M | -7.6x | --- |
Heron Therapeutics Inc | 162.7M | -6.2x | --- |
Company Information
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Contact Information
- Headquarters
- 2 Holtzman St., Science ParkREHOVOT, Israel 7670402
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Lilach Asher Topilsky
- Chief Executive Officer
- Amir London
- Deputy Chairman of the Board
- David Tsur
- Chief Financial Officer
- Chaime Orlev
- Senior Vice President - Scientific Affairs
- Ruth Wolfson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $337.5M |
|---|---|
Revenue (TTM) | $158.4M |
Shares Outstanding | 57.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $0.31 |
Book Value | $4.25 |
P/E Ratio | 18.7x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | 11.8x |
Operating Margin | 11.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
